{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:33:08Z","timestamp":1787502788990,"version":"build-2736575974"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077163","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T17:29:33Z","timestamp":1381253373000},"page":"e77163","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis"],"prefix":"10.1371","volume":"8","author":[{"given":"Signe","family":"Modvig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Degn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig P.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik B. W.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikte","family":"Wanscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sellebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette L.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"ref1","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up?","volume":"13","author":"PK Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","article-title":"Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis","volume":"184","author":"LK Peterson","year":"2007","journal-title":"J Neuroimmunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"R Dobson","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"MS Freedman","year":"2005","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3181a0fe3f","article-title":"Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis","volume":"72","author":"CE Teunissen","year":"2009","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e11986","DOI":"10.1371\/journal.pone.0011986","article-title":"The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)","volume":"5","author":"J Brettschneider","year":"2010","journal-title":"PLOS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"M Comabella","year":"2010","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0361-9230(03)00097-2","article-title":"Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain","volume":"61","author":"F Sellebjerg","year":"2003","journal-title":"Res Bull"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-006-9022-6","article-title":"Matrix metalloproteinase-9 and autoimmune diseases","volume":"26","author":"M Ram","year":"2006","journal-title":"J Clin Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","article-title":"Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system","volume":"127","author":"TL S\u00f8rensen","year":"2002","journal-title":"J Neuroimmunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"M Khademi","year":"2011","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"B Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"CF Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"CG Lee","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/030097401753180381","article-title":"Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction","volume":"30","author":"JS Johansen","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"D Bonneh-Barkay","year":"2010","journal-title":"J Neuroinflammation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1352458510392619","article-title":"Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis","volume":"17","author":"J Correale","year":"2011","journal-title":"Mult Scler"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"D Chabas","year":"2001","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1415","article-title":"Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells","volume":"8","author":"EM Hur","year":"2007","journal-title":"Nat Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1352458510382247","article-title":"Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis","volume":"17","author":"L B\u00f6rnsen","year":"2011","journal-title":"Mult Scler"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-1331.2009.02532.x","article-title":"The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers","volume":"16","author":"M Khademi","year":"2009","journal-title":"Eur J Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archneur.65.5.633","article-title":"Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis","volume":"65","author":"M Braitch","year":"2008","journal-title":"Arch Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneurol.2007.33","article-title":"Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis","volume":"65","author":"SA Chowdhury","year":"2008","journal-title":"Arch Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","article-title":"Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients","volume":"155","author":"MH Vogt","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e63172","DOI":"10.1371\/journal.pone.0063172","article-title":"Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers","volume":"8","author":"M Khademi","year":"2013","journal-title":"PLOS ONE"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS","volume":"61","author":"C Malmestr\u00f6m","year":"2003","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1191\/1352458505ms1218oa","article-title":"Acute axonal damage predicts clinical outcome in patients with multiple sclerosis","volume":"11","author":"ET Lim","year":"2005","journal-title":"Mult Scler"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis","volume":"12","author":"J Brettschneider","year":"2006","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"JN Lycke","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(01)00455-6","article-title":"Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability","volume":"122","author":"YK Semra","year":"2002","journal-title":"J Neuroimmunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1352458512458010","article-title":"CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome","volume":"19","author":"M Khalil","year":"2013","journal-title":"Mult Scler"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/135245859800400603","article-title":"Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis","volume":"4","author":"F Sellebjerg","year":"1998","journal-title":"Mult Scler"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","article-title":"Multiple sclerosis cerebrospinal fluid biomarkers","volume":"22","author":"G Giovannoni","year":"2006","journal-title":"Dis Markers"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1007\/s00415-012-6551-1","article-title":"CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis","volume":"259","author":"H Horwitz","year":"2012","journal-title":"J Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","article-title":"Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings","volume":"50","author":"M S\u00f6derstr\u00f6m","year":"1998","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1352458509355068","article-title":"Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid","volume":"16","author":"J Mellerg\u00e5rd","year":"2010","journal-title":"Mult Scler"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:02:15Z","timestamp":1589000535000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077163"}},"subtitle":[],"editor":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077163","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}